A Study Evaluating the Efficacy and Safety of Adding Symlin® to Lantus® (Insulin Glargine) in Subjects With Type 2 Diabetes

Research Site, Phoenix

Research Site, Concord

Research Site, La Jolla

Research Site, Los Gatos

Research Site, Salinas

Research Site, Walnut Creek

Research Site, Denver

Research Site, New Britain

Research Site, Washington D.C.

Research Site, Palm Harbor

Research Site, Atlanta

Research Site, Indianapolis

Research Site, Wichita

Research Site, Lexington

Research Site, Baton Rouge

Research Site, Bloomfield Hills

Research Site, Detroit

Research Site, Grand Rapids

Research Site, Chesterfield

Research Site, Butte

Research Site, Omaha

Research Site, Charlotte

Research Site, Durham

Research Site, Cincinnati

Research Site, Oklahoma City

Research Site, Medford

Research Site, Portland

Research Site, Philadelphia

Research Site, Tipton

Research Site, Nashville

Research Site, Dallas

Research Site, Charlottesville

Research Site, Olympia

Research Site, Spokane